Aarti Drugs Ltd

NSE: AARTIDRUGS · BSE: 524348 · Pharmaceuticals & Biotechnology · 12 announcements

Share price: ₹427.40
Market cap: ₹3,901 Cr
Revenue (annual): ₹2,565 Cr
Net profit (annual): ₹194.9 Cr
P/E (TTM): 20.4×Sector 50.4×
Promoter holding: 54.43%-0.60% QoQ
FII holding: 1.52%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 2 Management Change 1 Earnings Call 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

26 Sep 2026 20:16 IST BSE

Earnings Call

Aarti Drugs Investor Presentation: Key Takeaways

Aarti Drugs reports Q1 FY27 revenue of ₹704 Cr, up 19% YoY. Management focuses on scaling regulated market sales through high-margin formulations and oncology backward integration.

Open call summary → Read the filing ↗